Allogene Therapeutics Inc (ALLO) earnings · $258.1M cap
These earnings events as JSON? API free 100/dayAllogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
This ALLO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ALLO revenue for 2025-12-31 was $0. Net income was -$190.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ALLO currently screens at market cap $258.1M.
When the next ALLO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ALLO research stays on the stock page; the tape stays on the quote page.
ALLO earnings FAQ
What is ALLO's latest net income?
Latest cached Allogene Therapeutics Inc (ALLO) net income was -$190.9M. Statements: https://lician.com/financials/allo
What is ALLO's latest diluted EPS?
Latest cached Allogene Therapeutics Inc (ALLO) diluted EPS for Dec 31, 2025 was -$0.87.
What period does the latest ALLO earnings print cover?
The latest cached Allogene Therapeutics Inc (ALLO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are ALLO earnings listed?
Cached earnings facts for Allogene Therapeutics Inc (ALLO) are listed at https://lician.com/earnings/allo. Statements: https://lician.com/financials/allo
Not investment advice.